Sight plus by GiveVision
Pfizer has welcomed a trio of innovative start-ups into its London Healthcare Hub in a bid to help them break into the NHS.
Pfizer has announced that Echo, Cera and GiveVision will form the first cohort of healthtech start-ups to be supported by the Pfizer Healthcare Hub: London.
The three start-ups will work with Pfizer to identify the areas they can most benefit from support over the next 12 months, with the aim of helping them towards getting their technology adopted in the NHS within a year.
The start-ups will have access to Pfizer’s network of partners, like the NHS, who share the goal of improving experiences for doctors and outcomes for patients.
The Pfizer Healthcare Hub: London is a new initiative from Pfizer which aims to support established start-up companies innovating at the cross-section between health and technology to grow.
Echo, Cera and GiveVision were chosen following a rigorous selection process including an initial application and a judging day hosted at Pfizer’s UK head office.
Pfizer UK’s medical director, Dr. Berkeley Phillips, said: “We were deeply impressed by the quality of healthtech start-ups operating in the UK who applied to be a part of the Healthcare Hub.
"It was an incredibly tough decision to narrow the shortlist down to a final three, but Echo, Cera and GiveVision stood out with their ability to demonstrate how their technology could deliver real benefits across our health system today.
“We’re excited to be working with them over the next year as part of our wider programme of digital innovation and look forward to seeing the impact of their technology on clinicians and patients.”
GiveVision is the company behind SightPlus, a wearable headset developed to help improve vision for certain forms of visual impairment.
Its founder and CEO, Stan Karpenko, said: “We founded GiveVision because we saw the potential of technology to make a difference where it’s needed most. Working with Pfizer will help us to put our technology into the hands of those that need it most to positively impact lives.”
Echo provides a simple, free and secure app that lets people order their NHS prescriptions and get medication delivered directly to their home.
Stephen Bourke, co-founder and CXO, added: “We’re thrilled to have been selected by Pfizer to take part in the first year of the Healthcare Hub.
"We passionately believe technology can make life easier for patients and doctors alike and look forward to working together toward a system that promotes innovation to drive efficiency, cost savings and better health outcomes.”
Cera is a technology-enabled home care provider. The start-up works to provide consistent, transparent and comprehensive care using automatic matching, online care reports, competitive pay and strategic partnerships.
Dr Ben Maruthappu, co-founder and president of Cera, said: “Pfizer’s knowledge of and relationships with the UK healthcare system will be invaluable in helping Cera scale over the year ahead. Our aim is to work together to radically improve how homecare is delivered in London and beyond, making it quicker, more reliable, more transparent and of the highest quality.
“Our partnership with Pfizer will also be instrumental in helping us deliver medicines and new therapeutics to the elderly, which could be life-changing,” he added.